High-Density Epicardial Activation Mapping to Optimize the Site for Video-Thoracoscopic Left Ventricular Lead Implant

Optimization of Left Ventricular Lead Position Background The left ventricular (LV) lead local electrogram (EGM) delay from the beginning of the QRS complex (QLV) is considered a strong predictor of response to cardiac resynchronization therapy. We have developed a method for fast epicardial QLV map...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular electrophysiology Vol. 25; no. 8; pp. 882 - 888
Main Authors POLASEK, ROSTISLAV, SKALSKY, IVO, WICHTERLE, DAN, MARTINCA, TOMAS, HANULIAKOVA, JANA, ROUBICEK, TOMAS, BAHNIK, JAN, JANSOVA, HELENA, PIRK, JAN, KAUTZNER, JOSEF
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.08.2014
Wiley Subscription Services, Inc
BlackWell Publishing Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Optimization of Left Ventricular Lead Position Background The left ventricular (LV) lead local electrogram (EGM) delay from the beginning of the QRS complex (QLV) is considered a strong predictor of response to cardiac resynchronization therapy. We have developed a method for fast epicardial QLV mapping during video‐thoracoscopic surgery to guide LV lead placement. Methods A three‐port, video‐thoracoscopic approach was used for LV free wall epicardial mapping and lead implantation. A decapolar electrophysiological catheter was introduced through one port and systematically attached to multiple accessible LV sites. The pacing lead was targeted to the site with maximum QLV. The LV free wall activation pattern was analyzed in 16 pre‐specified anatomical segments. Results We implanted LV leads in 13 patients with LBBB or IVCD. The procedural and mapping times were 142 ± 39 minutes and 20 ± 9 minutes, respectively. A total of 15.0 ± 2.2 LV segments were mappable with variable spatial distribution of QLV‐optimum. The QLV ratio (QLV/QRSd) at the optimum segment was significantly higher (by 0.17 ± 0.08, p < 0.00001) as compared to an empirical midventricular lateral segment. The LV lead was implanted at the optimum segment in 11 patients (at an adjacent segment in 2 patients) achieving a QLV ratio of 0.82 ± 0.09 (range 0.63–0.93) and 99.5 ± 0.6% match with intraprocedural mapping. Conclusion Video‐thoracoscopic LV lead implantation can be effectively and safely guided by epicardial QLV mapping. This strategy was highly successful in targeting the selected LV segment and resulted in significantly higher QLV ratios compared to an empirical midventricular lateral segment.
Bibliography:istex:DAF73D4365AA4BAD3C6150257F81E76081362E3F
ark:/67375/WNG-QKFG59PN-P
ArticleID:JCE12430
R. Polasek reports receiving lecture fees from St. Jude Medical and Medtronic. J. Kautzner reports receiving payment for board membership and lecture fees from Biosense Webster, Boston Scientific, and St. Jude Medical; lecture fees from Biotronik and Medtronic. Other authors: No disclosures.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:1045-3873
1540-8167
1540-8167
DOI:10.1111/jce.12430